Smoots SG, Schreiber AR, Jackson MM, Bagby SM, et al. Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis. Breast Cancer Res 2024;26:35.
PMID: 38429789